Debts, disputes and a ‘shadow CEO’: The curious case of Truspine June 18, 2024 Truspine Technologies has failed to take off since it floated nearly four years ago - and some are arguing this failure merits further investigation by City regulators. City A.M. takes a closer look at the firm’s labyrinthine history, uncovering a myriad of debts, disputes and detractors
Exclusive: Why this London-based AI firm has picked Aquis for its float next month June 12, 2024 Pri0r1ty AI automates tasks like writing press releases, regulatory news, and social media content, typically handled by multiple external agencies.
Truspine chief resigns ‘with immediate effect’ amid investor efforts to oust him May 7, 2024 The chief executive of a London-listed medical technology firm has resigned following investor efforts to oust him and the chief financial officer from the company.
Investors in London-listed medical tech firm continue battle to oust top brass April 24, 2024 Investors in a London-listed medical technology firm are continuing their campaign to oust the company’s top brass as its share price languishes.
Aquis: Profit jumps 15 per cent for fledgling London exchange March 21, 2024 Exchange Aquis has reported 15 per cent growth in profit before tax despite challenging market conditions last year, with all arms of the business bringing in new revenue. In the company’s full-year results for 2023, it reported net revenue of £22.7m, up 13 per cent from the year before. Profit before tax came in at [...]